AndradeRG,RibeiroMA,Namen-LopesMS,SilvaSM,BasquesFV,RibasJG, 2010.Evaluation of the use of real-time PCR for human T-cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors,Rev Soc Bras Med Trop 43 111 -5
BlajchmanMA, 2002.Incidence and significance of the bacterial contamination of blood components,Dev Biol 108 59 -67
McDonaldCP,BlajchmanMA,BarbaraJAJ,ReganFAM,ContrerasMC, 2002.Bacterial contamination in blood and blood components,Transfusion Microbiology 87 -
StörmerM,VollmerT., 2014.Diagnostic methods for platelet bacteria screening: Current status and developments,Transfus Med Hemother 41 19 -27
PalavecinoE,YomtovianR, 2003.Risk and prevention of transfusion-related sepsis,Curr Opin Hematol 10 434 -9
DreierJ,StörmerM, 2004.Kleesiek K. Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates,J Clin Microbiol 42 4759 -64
SusanneM., 2013.Current methods for the reduction of blood-borne pathogens: A comprehensive literature review,Blood Transfus 11 343 -8
SpringerTA,ZhuJ,XiaoT., 2008.Structural basis for distinctive recognition of fi brinogen γC peptide by the platelet integrin αIIbβ3,J Cell Biol 182 791 -800
Schneidman-DuhovnyD,InbarY,NussinovR,WolfsonHJ,DockP,DockS, 2005.Servers for rigid and symmetric docking,Nucleic Acids Res 33 W363 -7
MashiachE,Schneidman-DuhovnyD,AndrusierN,NussinovR,WolfsonHJ.,Dock, 2008.A web server for fast interaction refinement in molecular docking,Nucleic Acids Res 36 W229 -32
KerkhoffsJL,van PuttenWL,NovotnyVM,Te BoekhorstPA,SchipperusMR,ZwagingaJJ, 2010.Clinical effectiveness of leucoreduced, pooled donor platelet concentrates, stored in plasma or additive solution with and without pathogen reduction,Br J Haematol 150 209 -17
VamvakasEC, 2012.Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system,Vox Sang 102 302 -16
SlichterSJ,RaifeTJ,DavisK,RheinschmidtM,BuchholzDH,CorashL, 2006.Platelets photochemically treated with Amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia,Transfusion 46 731 -40
2014.Pathogen inactivation technologies for cellular blood components: An update,Transfus Med Hemother 41 309 -25
ParidaP,YadavRNS, 2012.Comparative docking study of M1 protein (influenza virus) to check drug efficacy,Int J Pharm Pharm Sci 4 243 -6
PatilR,DasS,StanleyA,YadavL,SudhakarA,VarmaAK, 2010.Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drugdesigning,PLoS One 5 e12029 -
YuanJ,RenJ,WangY,HeX,ZhaoY, 2016.Acteoside binds to caspase-3 and exerts neuroprotection in the rotenone rat model of parkinson's disease,PLoS One 11 e0162696 -
NguyenCT,TanakaK,CaoY,ChoSH,XuD,StaceyG, 2016.Computational analysis of the ligand binding site of the extracellular ATP receptor, DORN1,PLoS One 11 e0161894 -
SinghVK,KumarN,KalsanM,SainiA,ChandraR., 2016.A novel peptide thrombopoietin mimetic designing and optimization using computational approach,Front Bioeng Biotechnol 4 69 -
NusratS,SiddiqiMK,ZamanM,ZaidiN,AjmalMR,AlamP, 2016.A comprehensive spectroscopic and computational investigation to probe the interaction of antineoplastic drug nordihydroguaiaretic acid with serum albumins,PLoS One 7 e0158833 -